Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.3809 | 0.3809 |
Schistosoma mansoni | amine oxidase | 0.0016 | 0.0494 | 0.1295 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0016 | 0.0494 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0 | 0.5 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0016 | 0.0494 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0007 | 0 | 0.5 |
Entamoeba histolytica | SWIRM domain protein | 0.0007 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0846 | 0.0845 |
Loa Loa (eye worm) | hypothetical protein | 0.019 | 0.9706 | 0.9706 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0016 | 0.0494 | 0.5 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0023 | 0.0846 | 0.0871 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0016 | 0.0494 | 1 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0016 | 0.0494 | 0.5 |
Mycobacterium ulcerans | monoamine oxidase | 0.0016 | 0.0494 | 0.5 |
Brugia malayi | Myb-like DNA-binding domain containing protein | 0.019 | 0.9706 | 1 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0016 | 0.0494 | 0.5 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0016 | 0.0494 | 0.1295 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.4161 | 0.4161 |
Entamoeba histolytica | hypothetical protein | 0.0007 | 0 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0016 | 0.0494 | 0.1295 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0016 | 0.0494 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0079 | 0.3809 | 1 |
Mycobacterium ulcerans | oxidoreductase | 0.0016 | 0.0494 | 0.5 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0016 | 0.0494 | 0.5 |
Brugia malayi | SWIRM domain containing protein | 0.0085 | 0.4161 | 0.4287 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0016 | 0.0494 | 0.5 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0016 | 0.0494 | 0.1295 |
Plasmodium vivax | hypothetical protein, conserved | 0.0016 | 0.0494 | 0.5 |
Giardia lamblia | hypothetical protein | 0.0007 | 0 | 0.5 |
Leishmania major | UDP-galactopyranose mutase | 0.0016 | 0.0494 | 0.5 |
Mycobacterium ulcerans | dehydrogenase | 0.0016 | 0.0494 | 0.5 |
Entamoeba histolytica | SWIRM domain protein | 0.0007 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0494 | 0.0493 |
Echinococcus multilocularis | 0.0016 | 0.0494 | 0.1295 | |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.3809 | 0.3809 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0016 | 0.0494 | 0.5 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0079 | 0.3809 | 1 |
Onchocerca volvulus | CoRest homolog | 0.0195 | 1 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0016 | 0.0494 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0016 | 0.0494 | 0.5 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0494 | 0.0508 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0016 | 0.0494 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0016 | 0.0494 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0016 | 0.0494 | 0.1295 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0494 | 0.0493 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0016 | 0.0494 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0016 | 0.0494 | 1 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0016 | 0.0494 | 0.5 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0079 | 0.3809 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 0.74 ug ml-1 | Cytotoxicity against human KB-VIN cells | ChEMBL. | 18161942 |
EC50 (functional) | = 0.79 ug ml-1 | Cytotoxicity against human KB cells | ChEMBL. | 18161942 |
EC50 (functional) | = 0.79 ug ml-1 | Cytotoxicity against human KB cells | ChEMBL. | 18161942 |
EC50 (functional) | = 1.47 ug ml-1 | Cytotoxicity against human MCF7 cells | ChEMBL. | 18161942 |
EC50 (functional) | = 1.47 ug ml-1 | Cytotoxicity against human MCF7 cells | ChEMBL. | 18161942 |
EC50 (functional) | = 4.77 ug ml-1 | Cytotoxicity against human A549 cells | ChEMBL. | 18161942 |
EC50 (functional) | = 4.77 ug ml-1 | Cytotoxicity against human A549 cells | ChEMBL. | 18161942 |
IC50 (binding) | = 4 uM | Inhibition of nitric oxide synthase in mouse BV2 cells assessed as inhibition of LPS-induced NO production | ChEMBL. | 18161942 |
Inhibition (binding) | = 23.1 % | Inhibition of NADPH oxidase in mouse BV2 cells assessed as NOX-dependent ROS production at 50 uM | ChEMBL. | 18161942 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.